Strainsforpains, Inc.

EBYHOTCHealthcare● Active

$0.16

+$0.00(+0.00%)

Market Cap$1888339

P/E Ratio—

52W High$0.19

52W Low$0.1605

Avg Volume465

Open$0.16

Beta-0.19

Overview

Strainsforpains, Inc. (EBYH) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

EBYH · free cash flow · updated Jun 15, 2026

Core FCF metrics

EBYH · FCF · TTM · margin & CAGR

Free cash flow was −$191,770 for FY2024 (fiscal year ending 2024-12-31), up 22.4% year-over-year The FCF margin was -106.4%.

FY2024 Free Cash Flow−$191,770▲ +22.4% YoY

Trailing 12M (TTM)−$188,913trailing 4 quarters sum

FCF Margin-106.4%−$191,770 ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 15, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

EBYH · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2024Latest−$191,771(0M)−$191,770▲ +22.4%-106.4%

FY2023−$247,187(0M)−$247,187▼ 11.4%-293.9%

FY2022−$221,985(0M)−$221,985▲ +27.9%—

FY2021−$308,031(0M)−$308,031▲ +81.2%—

FY2020−$140,847(2M)−$1.6M▼ 560.9%—

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

EBYH · P/FCF · FCF yield · FCF per share

Strainsforpains, Inc. (EBYH) reported negative free cash flow of −$0.00B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2024 · 2024-12-31

Cash flow statement summary

EBYH · cash flow statement · operating / investing / financing

For FY2024, Strainsforpains, Inc. generated −$0.2M in operating cash flow and spent 0M in capital expenditures, yielding −$0.2M in free cash flow.

Operating Activities

−$0.2M

Cash from core business operations

2024-12-31

Investing Activities

+$0.0M

CapEx, acquisitions & investments

2024-12-31

Financing Activities

+$0.2M

Buybacks, dividends & debt

2024-12-31

FCF FormulaOperating CF (−$0.2M) − |CapEx| (0M) = FCF (−$0.2M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

EBYH vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Strainsforpains, Inc.YOU

EBYH

−$191,770+22.4%-477.2%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Strainsforpains, Inc. (EBYH) reported free cash flow of −$191,770 for FY2024 (fiscal year ending 2024-12-31), up 22.4% year-over-year. The FCF margin was -106.4%.

Strainsforpains, Inc. has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 15 fiscal years.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

EBYH free cash flow · 8 questions

Strainsforpains, Inc. free cash flow was −$191,770 for FY2024, up 22.4% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$188,913.

EBYH free cash flowEBYH FCFEBYH FCF 2024EBYH free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Strainsforpains, Inc. · Strainsforpains, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026